User:Mr. Ibrahem/Methylprednisolone

Methylprednisolone, sold under the brand name Depo-Medrol among others, is a corticosteroid medication used to suppress the immune system and decrease inflammation. Conditions in which it is used include skin diseases, rheumatic disorders, allergies, asthma, croup, COPD, certain cancers, multiple sclerosis, and as add-on therapy for tuberculosis. It is given by mouth, by injection into a vein or muscle, or applied to the skin.

Serious side effects may include mental health problems and an increased risk of infection. Common side effects with long-term use include osteoporosis, cataracts, weakness, easy bruising, and yeast infections. For pregnant women, short-term use around the time of delivery is safe for the baby; however, long-term use during pregnancy may result in harm. Methylprednisolone is in the glucocorticoid family of medication.

Methylprednisolone was approved for medical use in 1955. It is on the World Health Organization's List of Essential Medicines. Methylprednisolone is available as a generic medication. In 2017, it was the 157th most commonly prescribed medication in the United States, with more than four million prescriptions.